References
- Garson A Jr, Gillette PC, McNamara DG. Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr 1981;98:875–882.
- Deal BJ. Supraventricular tachycardia mechanisms and natural history. In: Deal BJ, Wolff G, Gelband H, editors. Current concepts in diagnosis and management of arrhythmias in infants and children. Armonk (NY): Futura Publishing; 1998. pp 117–143.
- Von Bernuth G, Engelhardt W, Kramer HH, Singer H, Schneider P, Ulmer H, Brodherr-Heberlein S, Kienast W, Lang D, Lindinger A, et al Atrial automatic tachycardia in infancy and childhood. Eur Heart J 1992;13:1410–1415.
- Vaughan Williams EM. Classification of antiarrhythmic drugs. In: Sandoe E, Flensted-Jensen E, Olsen EH, editors. Symposium on cardiac arrhythmias. Denmark: Astra; 1970. pp 449–501.
- Radford D. Side effects of verapamil in infants. Arch Dis Child 1983;58:465–466.
- Till JA, Shinebourne EA, Rowland E, Ward DE, Bhamra R, Haga P, Johnston A, Holt DW. Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics. Br Heart J 1989;62:133–139.
- Ackland F, Singh R, Thayyil S. Flecainide induced ventricular fibrillation in a neonate. Heart 2003;89:1261.
- Pfammatter JP, Stocker FP. Re-entrant supraventricular tachycardia in infancy: current role of prophylactic digoxin treatment. Eur J Pediatr 1998;157:101–106.
- Perry JC. Pharmacologic therapy of arrhythmias. In: Deal BJ, Wolff G, Gelband H, editors. Current concepts in diagnosis and management of arrhythmias in infants and children. Armonk, (NY): Futura Publishing; 1998. pp 267–305.
- Weindling SN, Saul JP, Walsh EP. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants. Am Heart J 1996;131:66–72.
- Trippel DL, Gillette PC. Atenolol in children with supraventricular tachycardia. Am J Cardiol 1989;64:233–236.
- O'Sullivan JJ, Gardiner HM, Wren C. Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants? J Am Coll Cardiol 1995;26:991–994.
- Fish FA, Gillette PC, Benson DW Jr. Proarrhythmia, cardiac arrest and sudden death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 1991;18:356–365.
- Reimer A, Paul T, Kallfelz HC. Efficacy and safety of intravenous and oral propafenone in pediatric cardiac dyshythmias. Am J Cardiol 1991;68:741–744.
- Janousek J, Paul T, Reimer A, Kallfelz HC. Usefulness of propafenone for supraventricular arrhythmias in infants and children. Am J Cardiol 1993;72:294–300.
- Pfammatter JP, Paul T. New antiarrhythmic drug in pediatric use: sotalol. Pediatr Cardiol 1997;18:28–34.
- Pfammatter JP, Paul T, Lehmann C, Kallfelz HC. Efficacy and proarrhythmia of oral sotalol in pediatric patients. J Am Coll Cardiol 1995;26:1002–1007.
- Kugler JD, Danford DA. Management of infants, children and adolescents with paroxysmal supraventricular tachycardia. J Pediatr 1996;129:324–338.
- Guccione P, Paul T, Garson A Jr. Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol 1990;15:1118–1124.
- Paul T, Guccione P. New antiarrhythmic drug in pediatric use: amiodarone. Pediatr Cardiol 1994;15:132–138.